Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells

IJMS, Free Full-Text

Cancers, Free Full-Text

Mechanism of Sodium Valproate Combined with Decitabine in Inhibiting Hepatocellular Carcinoma Cells Epithelial-Mesenchymal Transition and Invasion and Metastasis Based on p38 Mitogen-Activated Protein Kinases/Heat Shock Protein 27 Regulating

Valproate-Induced Epigenetic Upregulation of Hypothalamic Fto Expression Potentially Linked with Weight Gain

DNA methylation status. The 5.8S and H3 histone genes, which lack HpaII

TET protein inhibitors: Potential and limitations - ScienceDirect

Combination treatment with DAC and Pano enhanced reactivation of

Cells, Free Full-Text

PDF) Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells

Exposure to hypomethylating 5-aza-2′-deoxycytidine (decitabine) causes rapid, severe DNA damage, telomere elongation and mitotic dysfunction in human WIL2-NS cells - ScienceDirect

Transcriptome and methylome changes in U937 cells upon treatment with

Cytometric assessment of CD133− and CD133+ and their cell cycle in

Sodium valproate (VPA) interactions with DNA and histones - ScienceDirect

Sodium valproate (VPA) interactions with DNA and histones - ScienceDirect

DNA demethylation by 5-aza-2′-deoxycytidine is imprinted, targeted to euchromatin, and has limited transcriptional consequences, Epigenetics & Chromatin